Compare Amylx Pharmaceuticals Inc (AMLX) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs First Trust Cloud Computing ETF — how do they compare? Amylx Pharmaceuticals Inc trades at $23.49 (market cap $2.64B), while First Trust Cloud Computing ETF trades at $163. Which is the better fit depends on your goals.
| AMLX | SKYY | |
|---|---|---|
Market Cap | $2.64B | — |
Sector | Health | — |
52-Week High | $24.19 | $161.09 |
52-Week Low | $7.82 | $104.16 |
Enterprise Value | $2.39B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMLX trades at $23.35, up 3.0% today, with a bullish technical signal from moving averages. The company reported a net loss of $144.74M in 2025, with negative ROE and ROA, but maintains a strong cash position of $250.8M extending into 2028. Key near-term catalyst is the Phase 3 LUCIDITY trial readout for avexitide expected in late August or early September 2026, which could drive significant stock movement.
The investment case hinges on successful clinical outcomes; a positive readout may support the consensus price target of $30.00, but persistent losses and high P/B ratio of 11.02 pose risks. Analyst sentiment is overwhelmingly bullish with 91% buy ratings, though recent earnings misses highlight execution challenges.
SKYY (First Trust Cloud Computing ETF) trades at $162.56, up 1.11% with strong technical momentum as moving averages signal bullish sentiment. The ETF provides diversified exposure to cloud infrastructure, software, and AI companies, benefiting from secular trends in digital transformation. Recent news highlights institutional interest in cloud computing ETFs as AI adoption accelerates.
The outlook remains positive given cloud migration trends and AI infrastructure investments, though overbought technical indicators suggest potential near-term consolidation. Key risks include regulatory developments in Europe's tech sovereignty initiatives and competitive pressures in the cloud computing sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
